ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 198 filers reported holding ROYALTY PHARMA PLC in Q4 2020. The put-call ratio across all filers is 2.07 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $541,917 | -13.6% | 20,071 | -1.7% | 0.00% | 0.0% |
| Q2 2023 | $627,037 | -18.6% | 20,418 | -4.5% | 0.00% | 0.0% |
| Q1 2023 | $770,393 | +12.3% | 21,382 | +25.3% | 0.00% | 0.0% |
| Q3 2022 | $686,000 | -14.8% | 17,065 | -10.9% | 0.00% | 0.0% |
| Q2 2022 | $805,000 | +128.0% | 19,144 | +116.2% | 0.00% | – |
| Q4 2021 | $353,000 | -65.8% | 8,856 | -69.0% | 0.00% | -100.0% |
| Q3 2021 | $1,031,000 | +1.0% | 28,534 | +14.6% | 0.00% | 0.0% |
| Q2 2021 | $1,021,000 | -6.0% | 24,900 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $1,086,000 | -12.8% | 24,900 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $1,246,000 | – | 24,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $294,957,000 | 88.74% |
| Vantage Consulting Group Inc | 8,705,551 | $379,735,000 | 76.23% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $116,930,000 | 72.07% |
| HARVARD MANAGEMENT CO INC | 10,714,284 | $467,357,000 | 26.11% |
| ROBERT WOOD JOHNSON FOUNDATION | 970,151 | $4,231,798,000 | 21.59% |
| Brown University | 381,759 | $16,652,000 | 11.44% |
| Overbrook Management Corp | 771,155 | $33,638,000 | 7.48% |
| SpiderRock Advisors, LLC | 778,800 | $34,236,000 | 4.79% |
| Renaissance Capital LLC | 452,948 | $19,758,000 | 2.93% |
| Lagoda Investment Management, L.P. | 104,835 | $4,573,000 | 2.28% |